Translational Medical Sciences
Yubin Zhou’s lab is exploring the frontiers of calcium signaling, optogenetics, immunoengineering and molecular therapy research by combining biophysics, immunology, chemical biology, drug screening, computational biology and mouse genetics. He and his team are focused on elucidating the role of calcium channels and DNA modifications in health and diseases and designing better treatment and prevention strategies for cardiovascular disorders, autoimmune diseases and cancer. Ongoing research activities include discovering novel ion channels that govern intracellular calcium homeostasis and T cell activities; devising innovative optical actuators for remote control of cell signaling, (epi)genome editing and immunomodulation; and designing better treatment and prevention strategies for immunoinflammatory diseases and tumors. He is an associate professor at the Center for Translational Cancer Research at Texas A&M’s Institute of Biosciences and Technology in Houston. He earned a bachelor of medicine degree (MD equivalent) at Zhejiang University School of Medicine (China), and an MS in chemistry and Ph.D. in biochemistry from Georgia State University. He also held a clinical internship at the Second Affiliated Hospital at Zhejiang University and was a research fellow at the Immune Disease Institute at Harvard University Medical School.
Areas of Expertise
Texas A&M in the News
Test To Detect Preeclampsia Earlier In Pregnancy In Development At Texas A&M
New Technology Shows Promise For Safer Cancer Therapy
What Is Ozempic? Texas A&M Pharmacists Explain Drug Viral On Social Media